Type 2 Diabetes Mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female patients aged between 18-80 years 2. Type 2 diabetes for more than 5 years with last HbA1c done within three months of recruitment of more than 8%
Exclusion criteria
Exclusion criteria: 1. Patients with known allergies to rifaximin. 2. Patients who have taken any antibiotic within three months prior to the recruitment. 3. Patients who are on continuous proton pump inhibitors for more than one month duration at the time of recruitment 4. Patients who are on concurrent vitamin supplements at the time of recruitment. 5. Patients who have chronic lower gastro intestinal symptoms at the time of recruitment. 6. Patients who are pregnant or lactating
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycaemic control assessed by reduction in HbA1c value >1% and/or reduction in post-prandial blood glucose (PPBG) >10% from baseline [HbA1C: At baseline and at the end of three months after the commencement of the intervention PPBG: At baseline, and at the end of two weeks and four weeks after the commencement of the intervention] | — |
Secondary
| Measure | Time frame |
|---|---|
| None [None] | — |
Countries
Sri Lanka
Contacts
Professor in Medicine